Neoadjuvant Cemiplimab for the Treatment of Resectable NSCLC, HCC, and HNSCC in Adult Patients
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Clinical Trials Related to Non-small Cell Lung Cancer
Related studies linked through entity extraction aliases.
An Open-label Study of Encorafenib + Binimetinib in Patients With BRAFV600-mutant Non-small Cell Lung Cancer
- Status
- COMPLETED
- Phase
- PHASE2
CABozantinib in Non-Small Cell Lung Cancer (NSCLC) Patients With MET Deregulation
- Status
- UNKNOWN
- Phase
- PHASE2
Study of TQB2450 Combined With Anlotinib in Patients With Advanced Non-small Cell Lung Cancer（NSCLC）
- Status
- UNKNOWN
- Phase
- PHASE1
A Study of Anti-PD1 Antibody-activated TILs in Non-small Cell Lung Cancer
- Status
- UNKNOWN
- Phase
- PHASE1/PHASE2
Hypofractionated Radiotherapy Followed by Hypo-boost for Local Advanced NSCLC
- Status
- COMPLETED
- Phase
- PHASE2
Complication and Lung Function Impairment Prediction Using Perfusion and CT Air Trapping
- Status
- COMPLETED
- Phase
- N/A
Study of CTX-471 as a Monotherapy or in Combination With Pembrolizumab in Patients Post PD-1/PD-L1 Inhibitors in Metastatic or Locally Advanced Malignancies
- Status
- COMPLETED
- Phase
- PHASE1
A Study of Carboplatin-Paclitaxel/Nab-Paclitaxel Chemotherapy With or Without Pembrolizumab (MK-3475) in Adults With First Line Metastatic Squamous Non-small Cell Lung Cancer (MK-3475-407/KEYNOTE-407)-China Extension Study
- Status
- COMPLETED
- Phase
- PHASE3
LIFE - Lung Cancer, Immunotherapy, Frailty, Effect
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- N/A
MEchanisms of Resistance in EGFR Mutated Nonpretreated Advanced Lung Cancer Receiving OSimErtib
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Imaging Tumor-infiltrating T-cells in Non-small Cell Lung Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Study of Pembrolizumab (MK-3475) Versus Platinum-Based Chemotherapy for Participants With Programmed Cell Death-Ligand 1 (PD-L1)-Positive Advanced or Metastatic Non-Small Cell Lung Cancer (MK-3475-042/KEYNOTE-042)-China Extension Study
- Status
- COMPLETED
- Phase
- PHASE3
CM082 and JS001 in Patients With Advanced Non-Small Cell Lung Cancer (NSCLC).
- Status
- UNKNOWN
- Phase
- PHASE2
Safety and Efficacy of Lorbrena
- Status
- COMPLETED
- Phase
- N/A
M7824 With cCRT in Unresectable Stage III Non-small Cell Lung Cancer (NSCLC)
- Status
- TERMINATED
- Phase
- PHASE2
Study of an Immunotherapeutic, DPX-Survivac, in Combination With Low Dose Cyclophosphamide & Pembrolizumab, in Subjects With Selected Advanced & Recurrent Solid Tumors
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Study of Plasma NGS for Assessment, Characterization, Evaluation of Patients With ALK Resistance
- Status
- COMPLETED
- Phase
- N/A
Precision Immuno-Oncology for Advanced Non-small Cell Lung Cancer Patients With PD-1 ICI Resistance
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
A Phase 1/2, Open-label, Multi-center Study of the Safety and Efficacy of Alomfilimab (KY1044) as Single Agent and in Combination With Anti-PD-L1 (Atezolizumab) in Adult Patients With Selected Advanced Malignancies
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2